caffeic acid has been researched along with Infarction, Middle Cerebral Artery in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| da Silva, AT; de Andrade, GM; de Araújo Rodrigues, P; de Sousa Neves, JC; de Souza, CM; Fonteles, AA; Fontenele Menezes, AP; Pinheiro Fernandes, FD; Santos do Carmo, MR | 1 |
| Chu, LS; Fang, SH; Wang, ML; Wei, EQ; Ye, YL; Zhang, WP; Zhou, Y | 1 |
2 other study(ies) available for caffeic acid and Infarction, Middle Cerebral Artery
| Article | Year |
|---|---|
Caffeic acid protects mice from memory deficits induced by focal cerebral ischemia.
Topics: Animals; Brain Ischemia; Caffeic Acids; Caspase 3; Disease Models, Animal; Dose-Response Relationship, Drug; Gene Expression Regulation; Infarction, Middle Cerebral Artery; Male; Memory Disorders; Mice; Motor Activity; Neuroprotective Agents; Synaptophysin; Synaptosomal-Associated Protein 25; Time Factors | 2014 |
Caffeic acid ameliorates early and delayed brain injuries after focal cerebral ischemia in rats.
Topics: Animals; Antioxidants; Arachidonate 5-Lipoxygenase; Brain; Caffeic Acids; Cysteine; Infarction, Middle Cerebral Artery; Ischemic Attack, Transient; Leukotriene B4; Leukotrienes; Male; Neurons; Neuroprotective Agents; Rats; Rats, Sprague-Dawley | 2006 |